Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2021-06-24 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
Reply Slip for the First Extraordinary General Meeting of 2021 (Applicable to H Shareholders)
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a reply slip for the First Extraordinary General Meeting (EGM) of 2021 of Pharmaron Beijing Co., Ltd. It is a form for shareholders to confirm attendance at the EGM, including instructions on how to submit the slip and details about the meeting date and location. There is no financial data, report content, or voting results included. This document is related to the organization and attendance of a shareholder meeting, not the meeting materials or results themselves. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a reply slip for attendance and proxy indication rather than voting results or solicitation materials, it is most appropriate to classify it as Proxy Solicitation & Information Statement (PSI). The document length is short and it is a form related to shareholder meeting participation, not a report or announcement of results.
2021-06-24 English
Proxy Form for the Solicitation of Voting Rights by Independent Non-Executive Director ("Independent Director's Proxy Form") for the Second H Shares Class Meeting of 2021
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for the solicitation of voting rights by an independent non-executive director for a specific shareholders' meeting (Second H Shares Class Meeting of 2021). It includes instructions for shareholders on how to appoint a proxy and vote on special resolutions related to the 2021 Restricted A Share Incentive Scheme. This type of document is used to solicit votes and provide voting instructions ahead of a shareholder meeting, which aligns with the definition of Proxy Solicitation & Information Statement (PSI). It is not a report of voting results, nor is it a full annual or interim report, earnings release, or other financial report. The document is also longer than 5,000 characters and contains detailed voting instructions, confirming it is not merely an announcement or certification. Therefore, the appropriate classification is PSI.
2021-06-24 English
Proxy Form for the Solicitation of Voting Rights by Independent Non-Executive Director ("Independent Director's Proxy Form") for the First Extraordinary General Meeting of 2021
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for the solicitation of voting rights by an independent non-executive director for the First Extraordinary General Meeting (EGM) of 2021 of Pharmaron Beijing Co., Ltd. It includes instructions for shareholders to appoint a proxy and vote on special resolutions related to a restricted share incentive scheme. The content is focused on voting procedures and proxy appointment for a specific shareholder meeting, not the meeting materials themselves or the voting results. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2021-06-24 English
Form of Proxy for the Second H Shares Class Meeting of 2021
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for the Second H Shares Class Meeting of 2021 for Pharmaron Beijing Co., Ltd. It includes instructions for shareholders to appoint proxies to vote on special resolutions at a shareholder meeting. The content is related to voting procedures and proxy appointments for a specific shareholder meeting, not the meeting materials themselves or the voting results. This type of document is typically classified under Proxy Solicitation & Information Statement (PSI), as it is sent to shareholders to provide information and request votes for meetings.
2021-06-24 English
Form of Proxy for the First Extraordinary General Meeting of 2021 (Applicable to H Shareholders)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for the First Extraordinary General Meeting (EGM) of 2021 of Pharmaron Beijing Co., Ltd. It contains instructions for shareholders to appoint proxies to vote on various resolutions at the EGM, including special and ordinary resolutions. The content is related to voting procedures and proxy appointments for a shareholder meeting, not the meeting materials themselves or the voting results. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2021-06-24 English
ADOPTION OF A SHARE INCENTIVE SCHEME AND ASSESSMENT MANAGEMENT MEASURES&#x3b; ISSUE AND GRANT OF A SHARES PURSUANT TO SPECIFIC MANDATE&#x3b; AUTHORIZATION TO HANDLE MATTERS PERTAINING TO A SHARE INCEN
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed circular from the Board of Pharmaron Beijing Co., Ltd. regarding multiple proposed corporate actions including adoption of a restricted share incentive scheme, amendments to articles of association, capital reduction, and notices of extraordinary general meetings and class meetings. It includes definitions, a letter from the Board, and detailed explanations of proposals to be voted on at upcoming shareholder meetings. The document is not a financial report, earnings release, or audit report. It is not a proxy solicitation or voting results announcement but rather a comprehensive information circular sent to shareholders to inform them about the matters to be considered at the meetings. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. The length and content confirm it is the actual information statement, not just a brief notice or announcement.
2021-06-24 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.